Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Valsartan × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Heart Failure 1

Interventions

pembrolizumab 1105 Specimen Handling 741 Carboplatin 727 Cyclophosphamide 706 Magnetic Resonance Spectroscopy 689 Cisplatin 626 Nivolumab 603 Paclitaxel 550 Radiotherapy 492 Gemcitabine 481 Biopsy 453 Bevacizumab 409 Dexamethasone 394 fludarabine 347 Docetaxel 343 venetoclax 337 Fluorouracil 322 Oxaliplatin 322 atezolizumab 316 Capecitabine 315 Rituximab 308 durvalumab 294 Doxorubicin 275 Pemetrexed 271 Radiosurgery 271 Drug Therapy 267 Ipilimumab 266 Standard of Care 261 Lenalidomide 252 Radiation 250

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05194111 2026-03-13

TREAT-HF

Virginia Commonwealth University

Phase 1/2 Recruiting

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡